Compositions for treating cancer
US12403194B2 · kind B2 · utility
0Cited by
14References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 17, 2024 |
| Grant date | Sep 2, 2025 |
| Priority date | — |
| Expiry date | Oct 17, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2830/50
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides compositions and methods comprising recombinant particles suitable for specifically delivering one or more chimeric antigen receptors to immune effector cells in vivo.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.